-
Loading metrics
Open Access
Peer-reviewed
Research Article
The combination of LILRB4-targeting NK cell engagers and cGAS–STING agonists enhances the anti–multiple myeloma immune activity of NK cells
-
Meng Li ,
Contributed equally to this work with: Meng Li, Yuwei Zhao, Lizhou Zhao
Roles Conceptualization, Funding acquisition, Validation, Writing – original draft, Writing – review & editing
Affiliation Blood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan Province, China
⨯ -
Yuwei Zhao ,
Contributed equally to this work with: Meng Li, Yuwei Zhao, Lizhou Zhao
Roles Conceptualization, Formal analysis, Funding acquisition, Validation, Writing – original draft, Writing – review & editing
Affiliation Blood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan Province, China
⨯ -
Lizhou Zhao ,
Contributed equally to this work with: Meng Li, Yuwei Zhao, Lizhou Zhao
Roles Conceptualization, Data curation, Validation, Writing – original draft, Writing – review & editing
Affiliation Blood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan Province, China
⨯ -
Xue Chen,
Roles Investigation, Supervision
Affiliation Blood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan Province, China
⨯ -
Jianxun Kang,
Roles Resources, Supervision
Affiliation Blood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan Province, China
⨯ -
Aiping Tong,
Roles Conceptualization, Resources
Affiliation Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
⨯ -
Chen Yang,
Roles Methodology, Validation
Affiliation Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
⨯ -
Ping Wang,
Roles Data curation, Validation
Affiliation Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
⨯ -
Minjun Yang,
Roles Data curation, Methodology
Affiliation Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
⨯ -
Kejiang Wang,
Roles Formal analysis, Software
Affiliation The Department of Experimental Medicine, Meishan City People’s Hospital, Meishan, Sichuan Province, China
⨯ -
Jialiang Gao ,
Roles Conceptualization, Investigation, Resources, Writing – review & editing
* E-mail: xuemeifucdbc@163.com (XF); 14166185@qq.com (YL); 97349656@qq.com (JG)
Affiliation Blood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan Province, China
⨯ -
Ying Li ,
Roles Conceptualization, Formal analysis, Investigation, Resources, Writing – review & editing
* E-mail: xuemeifucdbc@163.com (XF); 14166185@qq.com (YL); 97349656@qq.com (JG)
Affiliation Blood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan Province, China
⨯ -
Xuemei Fu
Roles Conceptualization, Project administration, Resources, Writing – original draft, Writing – review & editing
* E-mail: xuemeifucdbc@163.com (XF); 14166185@qq.com (YL); 97349656@qq.com (JG)
Affiliation Blood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan Province, China
⨯
The combination of LILRB4-targeting NK cell engagers and cGAS–STING agonists enhances the anti–multiple myeloma immune activity of NK cells
- Meng Li,
- Yuwei Zhao,
- Lizhou Zhao,
- Xue Chen,
- Jianxun Kang,
- Aiping Tong,
- Chen Yang,
- Ping Wang,
- Minjun Yang,
- Kejiang Wang
- Published: December 19, 2025
- https://doi.org/10.1371/journal.pone.0339375